
Get full access for you and your coworkers.
Start a free company trial todayAlready a member? Log in.
While Genmab's partner Novartis can start launching sclerosis drug Kesimpta in Europe after receiving EU authorization, the process is well underway in the US – and it's going well, according to CEO Jan van de Winkel.
Already a member? Log in.